0.69%
10.26%
10.39%
26.87%
15.00%
2.60%
58.07%
AI Spotlight on VEEV
Company Description
Veeva Systems Inc.provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America.The company offers Veeva Commercial Cloud, a suite of software, data, and analytics solutions, which include Veeva customer relationship management (CRM) and Veeva Medical CRM, Veeva CLM, Veeva CRM MyInsights, Veeva CLM, Veeva CRM Approved Email, Veeva CRM Engage, Veeva Align, Veeva CRM Events Management, Veeva Nitro, Veeva OpenData, Veeva Link, Veeva Network, Veeva Crossix, Veeva Data Cloud, and MyVeeva for Patients; and Veeva Vault, a cloud-based enterprise content and data management applications for managing commercial functions, including sales and marketing, and medical content and communications, as well as research and development functions, such as clinical, regulatory, quality, and safety.
It also provides professional and support services in the areas of implementation and deployment planning and project management; requirements analysis, solution design, and configuration; systems environment management and deployment services; services focused on advancing or transforming business and operating processes related to Veeva solutions; technical consulting services related to data migration and systems integrations; training on its solutions; and ongoing managed services that include outsourced systems administration.The company was formerly known as Verticals onDemand, Inc.and changed its name to Veeva Systems Inc.
in April 2009.Veeva Systems Inc.was incorporated in 2007 and is headquartered in Pleasanton, California.
Market Data
| Last Price | 234.88 |
| Change Percentage | 0.69% |
| Open | 230 |
| Previous Close | 233.26 |
| Market Cap ( Millions) | 38133 |
| Volume | 348416 |
| Year High | 258.93 |
| Year Low | 170.25 |
| M A 50 | 223.07 |
| M A 200 | 206.42 |
Financial Ratios
| FCF Yield | 2.78% |
| Dividend Yield | 0.00% |
| ROE | 13.17% |
| Debt / Equity | 1.30% |
| Net Debt / EBIDTA | -145.74% |
| Price To Book | 6.91 |
| Price Earnings Ratio | 57.09 |
| Price To FCF | 35.98 |
| Price To sales | 14.34 |
| EV / EBITDA | 55.62 |
News
- Jan -29 - More Than 200 Companies Advance Trial Management with Veeva CTMS
- Jan -28 - Veeva Systems: Forget The Short-Term Volatility; The Long Term Is Promising
- Jan -27 - VEEV Stock Falls Despite Tie-Up to Streamline Customers' Operations
- Jan -24 - Veeva Systems (VEEV) Ascends While Market Falls: Some Facts to Note
- Jan -23 - Veeva and Zifo Partner to Accelerate Quality Control Modernization
- Jan -23 - 2 Growth Stocks to Buy in 2025 and Hold for a Decade
- Jan -16 - Veeva Systems (VEEV) Advances While Market Declines: Some Information for Investors
- Jan -13 - Veeva to Present at Upcoming Investor Conference
- Jan -10 - Veeva Systems (VEEV) Increases Despite Market Slip: Here's What You Need to Know
- Jan -09 - Veeva's Vault Is Safe-But What About Its CRM Offering
- Jan -07 - Veeva: My Software Pick For 2025
- Dec -19 - Veeva initiated with an Overweight at Stephens
- Dec -17 - Here's Why you Should Retain Veeva Systems Stock in Your Portfolio Now
- Dec -14 - Got $5,000? 3 Tech Stocks to Buy and Hold for the Long Term.
- Dec -12 - A Growing Number of Biopharmas Leverage Veeva Compass Patient to Improve Commercialization
- Dec -12 - 2 No-Brainer Growth Stocks to Buy and Hold Through 2025 and Beyond
- Dec -11 - Deciphering Veeva (VEEV) International Revenue Trends
- Dec -10 - Veeva Delivers Vault CRM Suite with Vault CRM Campaign Manager
- Dec -09 - Veeva to Present at Upcoming Investor Conference
- Dec -09 - Veeva Systems Q3 Earnings & Revenues Beat, Operating Margin Up Y/Y
Business Breakdown
Expected Mid-Term Growth
Segment n°1 -> Subscription
Expected Growth : 13 %
What the company do ?
Veeva Systems Inc.'s Subscription is a cloud-based solution for life sciences companies to manage customer subscriptions, track licenses, and automate renewals.
Why we expect these perspectives ?
Veeva Systems Inc.'s 13% subscription growth is driven by increasing adoption of cloud-based solutions in the life sciences industry, growing demand for digital transformation, and expansion into new markets. Additionally, the company's strong brand reputation, innovative products, and strategic partnerships contribute to its sustained growth.
Segment n°2 -> Professional Services and Other
Expected Growth : 11 %
What the company do ?
Professional Services and Other from Veeva Systems Inc. refers to revenue generated from consulting, implementation, and training services, as well as other miscellaneous revenue streams.
Why we expect these perspectives ?
Veeva Systems Inc.'s Professional Services and Other segment growth of 11% is driven by increasing adoption of cloud-based solutions, expansion into new markets, and growing demand for digital transformation in the life sciences industry. Additionally, the company's strategic partnerships, innovative product offerings, and high customer retention rates contribute to the segment's growth.
Veeva Systems Inc. Products
| Product Range | What is it ? |
|---|---|
| Veeva CRM | A cloud-based customer relationship management (CRM) solution designed specifically for the life sciences industry. |
| Veeva Vault | A cloud-based content management platform that enables life sciences companies to manage regulated content, including documents, images, and videos. |
| Veeva Network | A cloud-based master data management solution that enables life sciences companies to manage their customer and product data. |
| Veeva Commercial Cloud | A cloud-based commercial platform that enables life sciences companies to manage their commercial operations, including sales, marketing, and customer service. |
| Veeva QualityOne | A cloud-based quality management system (QMS) that enables life sciences companies to manage their quality processes, including document control, training, and audits. |
| Veeva R&D | A cloud-based research and development (R&D) platform that enables life sciences companies to manage their R&D processes, including clinical trials, regulatory submissions, and product development. |
Veeva Systems Inc.'s Porter Forces
Threat Of Substitutes
Veeva Systems Inc. has a low threat of substitutes due to its unique cloud-based software solutions for the life sciences industry, making it difficult for competitors to replicate its offerings.
Bargaining Power Of Customers
Veeva Systems Inc. has a medium bargaining power of customers, as its customers are primarily large pharmaceutical and biotechnology companies that have some negotiating power, but are also dependent on Veeva's specialized software solutions.
Bargaining Power Of Suppliers
Veeva Systems Inc. has a low bargaining power of suppliers, as it is a dominant player in the life sciences software market and has a strong negotiating position with its suppliers.
Threat Of New Entrants
Veeva Systems Inc. has a low threat of new entrants, as the life sciences software market is highly specialized and requires significant expertise and resources to enter, making it difficult for new competitors to emerge.
Intensity Of Rivalry
Veeva Systems Inc. operates in a moderately competitive market, with a few established players, but its strong brand recognition and customer loyalty help to mitigate the intensity of rivalry.
Capital Structure
| Value | |
|---|---|
| Debt Weight | 1.19% |
| Debt Cost | 3.95% |
| Equity Weight | 98.81% |
| Equity Cost | 7.74% |
| WACC | 7.69% |
| Leverage | 1.20% |
Veeva Systems Inc. : Quality Control
Veeva Systems Inc. passed 7 out of 9 key points:
Historical Valuation
Price/Earnings Ratio
Margin Valuation
Peers Valuation
Competitors
| Company | Rational |
|---|---|
| COR | Cencora, Inc. sources and distributes pharmaceutical products. Its U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and … |
| GEHC | GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United … |
| AMGN | Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat … |
| CNC | Centene Corporation operates as a multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. Its Managed Care segment offers health plan coverage … |
| HCA | HCA Healthcare, Inc., through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including … |
Peers Metrics
DCF BETA
Expected Cash-Flows
Scoring Insights
Peers Group Analysis
🥇
HCA Healthcare
A-Score
1-Year Total Return ->
🥈
Cencor
A-Score
1-Year Total Return ->
🥉
Amgen
A-Score
1-Year Total Return ->
4
Veeva Systems
A-Score
1-Year Total Return ->
5
Centene
A-Score
1-Year Total Return ->
6
